Connection of metastasis-free survival in breast cancer patients and an expression vector of multidrug resistance genes in tumor during neoadjuvant chemotherapy

Voprosy Onkologii

Volumn 59, Issue 3, 2013, Pages 334-340

  Litviakov, N V ^a   Garbukov, E Yu ^a   Slonimskaya, E M ^a,b   Tsyganov, M M ^a   Denisov, E V ^a   Vtorushin, S V ^a,b   Christenko, K Yu ^b   Zavyalova, M V ^a,b   Cherdyntseva, N V ^a,b  

^a ENERGY SYSTEMS INSTITUTE   (Russian Federation)

^b SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; ABCC1 PROTEIN; ABCC2 PROTEIN; ABCC5 PROTEIN; ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; GLUTATHIONE TRANSFERASE P1; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MVP PROTEIN; TAXANE DERIVATIVE; TUMOR MARKER; UNCLASSIFIED DRUG; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ABCB1 GENE; ABCC1 GENE; ABCC2 GENE; ABCC5 GENE; ABCG1 GENE; ABCG2 GENE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; DISTANT METASTASIS; DOWN REGULATION; EXPRESSION VECTOR; GENE; GENE EXPRESSION; GSTP1 GENE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS FREE SURVIVAL; MULTIDRUG RESISTANCE GENE; MVP GENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; UPREGULATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; BREAST TUMOR; CANCER STAGING; CHEMISTRY; DISEASE FREE SURVIVAL; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIDRUG RESISTANCE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84884773993     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Burger H., Foekens J.A., Look M.P. et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response // Clin Cancer Res - 2003. - Vol. 9. - P. 827-836.
2. Clark G.M. Prognostic and predictive factors for breast cancer // Breast Cancer - 1995. - Vol. 2. - P. 79-89.
3. Eechoute K., Sparreboom A., Burger H. et al. Drug transporters and imatinib treatment: implications for clinical practice //Clinical Cancer Research - 2011. - Vol. 17. - P. 406-415.
4. Filipits M., Pohl G., Rudas M. et al. Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group //J. Clin. Oncol. - 2005. - Vol. 23. - P. 1161-1168.
5. Glubb D.M., Innocenti F. Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters // WIREs Syst Biol Med - 2011-Vol. 3. - P. 299-313.
6. Gottesman M.M., Ling V. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research // FEBS letters - 2006. - Vol. 580. - P. 998-1009.
7. Kanzaki A., Toi M., Nakayama K. et al. Expression of multidrug resistance-related transporters in human breast carcinoma // Jpn J Cancer Res. 2001. - Vol. 92. - P. 452-458.
8. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations // J. Amer. Statist. Assoc. - 1958 - Vol. 53. - P. 457-481.
9. Leonessa F., Clarke R. ATP binding cassette transporters and drug resistance in breast cancer. // Endocr Relat Cancer - 2003. - Vol. 10. - P. 43-73.
10. Litviakov N.V., Cherdyntseva N.V., Tsyganov M.M. et al. Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response // Cancer Chemother. Pharmacol. - 2013. - Vol. 71. - P. 153-163.
11. Moureau-Zabotto L., Ricci S., Lefranc J.P. et al. Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients // Br J Cancer - 2006. - Vol. 94. - P. 473-480.
12. Perel'muter V.M., Zav'ialova M.V., Vtorushin S.V. et al.. [Genetic and clinical and pathological characteristics of breast cancer in premenopausal and postmenopausal women] // Adv Gerontol - 2008. - Vol. 21. - P. 643-653.
13. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR // Nucleic Acids Res - 2001. Vol. 29. - P. 45.
14. Reed K., Parissenti A.M. Epigenetic Regulation of ABCB1 Transporter Expression and Function // Current Pharmacog - 2010. - Vol. 8. - P. 218-231.
15. Schinkel A.H., Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview // Advanced Drug Delivery Rev. - 2003. - Vol. 55. - P. 3-29.
16. Schwartz G.F., Hortobagyi G.N. Proceedings of the Consensus Conference on Neoadjuvant Chemotherapy in Carcinoma of the Breast, April 26-28, 2003, Philadelphia, Pennsylvania // The Breast Journal - 2004. - Vol.10. - P. 273-294.
17. Sharma G., Mirza S., Parshad R. et al. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients // Clin Biochem - 2010. - Vol. 43. - P. 373-379.
18. Szakács G., Annereau J.P., Lababidi S. et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells // Cancer Cell - 2004. - Vol. 6. - P. P. 129-137.
19. Wind N.S., Holen I. Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies // Int. J. Breast Cancer 2011∧967419. - P. 1-12.
20. Wolmark N., Wang J., Mamounas E. et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 // JNCI Monographs - 2001. - P. 96-102.
21. Zavyalova M., Perelmuter V., Vtorushin S., et al. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis // Diagnost. Cytopathol. 2013. - Vol. 41 (3). - P. 279-282.